Clinical Trial Update: Voriconazole or Placebo in the Prophylaxis of Lung Infiltrates in Patients Undergoing Induction Chemotherapy for Acute Myelogenous Leukemia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating voriconazole prophylaxis versus placebo in patients with acute myeloid leukemia undergoing induction chemotherapy was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• VORICONAZOLE (Voriconazole)

Snippet

Sponsor: University of Cologne | Conditions: Leukemia, Myelocytic, Acute | Phase 3 | Status: TERMINATED